Patellar Tendinitis Market Size

Global Patellar Tendinitis Market Overview

Patellar Tendinitis Market Size was valued at USD 74.56 Billion in 2023. The Global Patellar Tendinitis industry is projected to grow from USD 78.45 Billion in 2024 to USD 201.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.45% during the forecast period (2024 - 2032).

Tendons are thick cords that attach the muscles to the bones. Inflammation of these tendons is known as tendinitis. Repetitive movement, injury or diseases conditions are main causes of the tendinitis, with severe pain, swelling or tenderness at the affected area. Use of over-the-counter drugs or pain relievers such as non-steroidal anti-inflammatory drugs (NSAIDs), rest therapy and physical therapy are commonly used treatment measures for this condition. 

Delayed diagnosis of patellar tendinitis may require a surgery to reduce pain, and improve the movement. Tendinitis is found to be prevalent among athletes or sports players as a result of continuous strain on the tendons due to a rigorous workout, running and other activities. Moreover, patellar tendinitis is an injury to the tendon connecting kneecap (patella). The patellar tendon works with the muscles at the front of the thigh to knee. Patellar tendinitis or tendonitis is also known as jumper's knee and is most common in athletes whose sports involve frequent jumping such as basketball and volleyball. However, even people who don't participate in jumping sports can get patellar tendinitis

Increasing prevalence of sports injury, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases are likely to fuel the market growth during the forecast period. Moreover, increasing geriatric population is boost the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. However, side-effects and higher treatment cost may hinder the Patellar Tendinitis Market growth during the forecast period.

Intended Audience

• Pharmaceutical and Biotechnological Companies


• Research and Development (R&D) Companies


• Ambulatory Care Centers


• Academic Institutes and Universities


• Market Research and Consulting Service Providers

Global Patellar Tendinitis Market Segmentations

The patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, it is segmented into the physical examination, imaging tests, and others. The imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).

The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. The medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others.

Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.

Global Patellar Tendinitis Market Regional Analysis

The Americas dominate the patellar tendinitis market owing to well-developed technology, increasing patient population for sports injury, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.

Europe holds the second position in the global patellar tendinitis market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.

The Asia Pacific is the fastest growing patellar tendinitis market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare sector is projected to lead the use of advanced equipment, which, in turn, may increase the Patellar Tendinitis Market growth in this region.   

On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.

Global Patellar Tendinitis Market Key Players

Some of key the players in the Patellar Tendinitis Market are: 

• Abbott (U.S.)


• Pfizer (U.S.)


• AstraZeneca (U.K)


• Bayer (Germany)


• Merck & Co. Inc. (Germany)


• GlaxoSmithKline plc (U.S.)


• Teva Pharmaceutical Industries (Israel)


• Boehringer Ingelheim Pharmaceuticals, Inc. (Germany)

Research Methodology 

Sources: Annual reports, Press release, White paper, and Company presentation